Recombinant Human SUCNR1 Protein，GST

The SUCNR1 gene encodes a receptor known as the succinate receptor 1, which plays a crucial role in various physiological processes, including the regulation of metabolism and inflammation. Research has indicated that SUCNR1 is involved in sensing metabolic changes in the body, particularly in response to succinate, a key intermediate in the tricarboxylic acid cycle. Abnormal SUCNR1 signaling has been implicated in several pathological conditions, including cardiovascular diseases, cancer, and metabolic disorders. Consequently, the study of SUCNR1 recombinant proteins has gained significant attention as a potential therapeutic target. Recombinant SUCNR1 proteins allow for the investigation of receptor function, ligand interaction, and downstream signaling pathways in controlled experimental settings. Understanding the structure and dynamics of SUCNR1 via recombinant technologies can provide insights into its role in disease mechanisms and may aid in the development of novel therapeutic approaches that modulate its activity. Furthermore, the production of SUCNR1 proteins in heterologous systems facilitates high-throughput screening of small molecules that could serve as SUCNR1 modulators, aiming to uncover new treatment strategies for various conditions associated with dysregulated succinate signaling. Overall, the research on SUCNR1 recombinant proteins is vital for unraveling the complexities of succinate signaling in health and disease, paving the way for innovative biomedical applications.